BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37314216)

  • 1. USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle.
    Song N; Deng L; Zeng L; He L; Liu C; Liu L; Fu R
    Mol Carcinog; 2023 Oct; 62(10):1487-1503. PubMed ID: 37314216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
    Lu Q; Lu D; Shao ZM; Li DQ
    Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
    Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
    J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP9X regulates centrosome duplication and promotes breast carcinogenesis.
    Li X; Song N; Liu L; Liu X; Ding X; Song X; Yang S; Shan L; Zhou X; Su D; Wang Y; Zhang Q; Cao C; Ma S; Yu N; Yang F; Wang Y; Yao Z; Shang Y; Shi L
    Nat Commun; 2017 Mar; 8():14866. PubMed ID: 28361952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
    Li H; Zheng B
    Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
    Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
    Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple-negative breast cancer by stabilizing Snail1.
    Guan T; Yang X; Liang H; Chen J; Chen Y; Zhu Y; Liu T
    J Cell Physiol; 2022 Jul; 237(7):2992-3000. PubMed ID: 35506169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma.
    Wang S; Huo X; Yang Y; Mo Y; Kollipara RK; Kittler R
    Cancer Lett; 2023 Jan; 552():215984. PubMed ID: 36330954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
    Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
    Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
    Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
    Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.
    Izrailit J; Jaiswal A; Zheng W; Moran MF; Reedijk M
    Oncogene; 2017 Feb; 36(8):1048-1057. PubMed ID: 27593927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The X-linked deubiquitinase USP9X is an integral component of centrosome.
    Wang Q; Tang Y; Xu Y; Xu S; Jiang Y; Dong Q; Zhou Y; Ge W
    J Biol Chem; 2017 Aug; 292(31):12874-12884. PubMed ID: 28620049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.
    Li L; Liu T; Li Y; Wu C; Luo K; Yin Y; Chen Y; Nowsheen S; Wu J; Lou Z; Yuan J
    Oncogene; 2018 May; 37(18):2422-2431. PubMed ID: 29449692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
    Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
    J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
    Sulkshane P; Pawar SN; Waghole R; Pawar SS; Rajput P; Uthale A; Oak S; Kalkar P; Wani H; Patil R; Nair S; Rane P; Teni T
    Br J Cancer; 2021 Aug; 125(4):547-560. PubMed ID: 34079080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinase USP9X stabilizes RNA m
    Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
    J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.